Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Steven F. Ethridge"'
Autor:
Steven F. Ethridge, Tara Smith, Wei Luo, Rebecca Rossetti, Laura G. Wesolowski, Kevin P. Delaney, Silvina Masciotra, S. Michele Owen
Publikováno v:
Sexually Transmitted Diseases. 47:S26-S31
Background There is benefit to early HIV-1 diagnosis and treatment, but there is no Food and Drug Administration-approved quantitative assay with a diagnostic claim. We compared the performance of the Hologic Aptima HIV-1 Quant (APT-Quant) and Aptima
Autor:
Lauren R. Violette, Andy Cornelius-Hudson, Madison Snidarich, Lisa A. Niemann, Sonny Michael Assennato, Allyson Ritchie, Neha Goel, Pollyanna R. Chavez, Steven F. Ethridge, David A. Katz, Helen Lee, Kevin P. Delaney, Joanne D. Stekler
Publikováno v:
J Acquir Immune Defic Syndr
Point-of-care (POC) nucleic acid tests (NATs) have potential to diagnose acute HIV infection and monitor persons taking pre-exposure prophylaxis or antiretroviral therapy (ART). POC NATs have not yet been evaluated in the US.From June 2018-March 2019
Autor:
Steven F. Ethridge, Sarah J McDougal, Hollie A Clark, Kevin P. Delaney, Andy Cornelius-Hudson, Laura G. Wesolowski, Vanessa McMahan, Lauren R Violette, Lisa A Niemann, Pollyanna R Chavez, David A. Katz, Joanne D. Stekler
Publikováno v:
JMIR Research Protocols
JMIR Research Protocols, Vol 9, Iss 1, p e16332 (2020)
JMIR Research Protocols, Vol 9, Iss 1, p e16332 (2020)
Background HIV testing guidelines provided by the Centers for Disease Control and Prevention (CDC) are continually changing to reflect advancements in new testing technology. Evaluation of existing and new point-of-care (POC) HIV tests is crucial to
Autor:
Monica M. Parker, Linda M. Styer, Salvacion Fordan, Pollyanna R Chavez, Timothy J. Sullivan, Steven F. Ethridge, Anne M. Gaynor, Laura G. Wesolowski, S. Berry Bennett, Kelly Wroblewski
Publikováno v:
Sexually transmitted diseases. 47(5S Suppl 1)
Background In 2016, HIV-2 nucleic acid testing (NAT) was added to a shared service program that conducts HIV-1 NAT for public health laboratories performing the recommended algorithm for diagnosing HIV. Here, we evaluate the usefulness of HIV-2 NAT i
Autor:
Laura G Wesolowski, Duncan A Mackellar, Steven F Ethridge, Julia H Zhu, S Michele Owen, Patrick S Sullivan, Post Marketing Surveillance Team
Publikováno v:
PLoS ONE, Vol 3, Iss 2, p e1524 (2008)
BACKGROUND: Reactive oral fluid and whole blood rapid HIV tests must be followed with a confirmatory test (Western blot (WB), immunofluorescent assay (IFA) or approved nucleic acid amplification test (NAAT)). When the confirmatory result is negative
Externí odkaz:
https://doaj.org/article/52a177909fd2461498166a4d49624d42
Autor:
Lauren R Violette, Sarah J McDougal, Andy Cornelius-Hudson, Joanne D. Stekler, Heather Bradley, Vanessa McMahan, David A. Katz, Steven F. Ethridge, Laura G. Wesolowski, Kevin P. Delaney, Lisa A Niemann, Pollyanna R Chavez
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 124
The performance of recently approved point-of-care (POC) HIV tests should be assessed using unprocessed specimens.To evaluate the sensitivity and specificity of four POC HIV tests using whole blood (WB) and two using oral fluid (OF) among persons rec
Autor:
Joanne D Stekler, Lauren R Violette, Hollie A Clark, Sarah J McDougal, Lisa A Niemann, David A Katz, Pollyanna R Chavez, Laura G Wesolowski, Steven F Ethridge, Vanessa M McMahan, Andy Cornelius-Hudson, Kevin P Delaney
BACKGROUND HIV testing guidelines provided by the Centers for Disease Control and Prevention (CDC) are continually changing to reflect advancements in new testing technology. Evaluation of existing and new point-of-care (POC) HIV tests is crucial to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ce639552a5901c2f438d79f6549988e
https://doi.org/10.2196/preprints.16332
https://doi.org/10.2196/preprints.16332
Autor:
Lauren R Violette, Lisa A Niemann, Vanessa M McMahan, David A Katz, Pollyanna R Chavez, Hollie A Clark, Andy Cornelius-Hudson, Steven F Ethridge, Sarah J McDougal, George Ure II, Joanne D Stekler, Kevin P Delaney
BACKGROUND Group sex events (GSEs) are common among cisgender men who have sex with men (MSM), pose a unique risk profile for HIV and sexually transmitted disease (STD) transmission, and may be on the rise, in part because of Web-based networking pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::884a8ea23173a792ea21ac10e77698f4
https://doi.org/10.2196/preprints.15426
https://doi.org/10.2196/preprints.15426
Autor:
Sherry M. Owen, Debra L. Hanson, Steven F. Ethridge, Laura G. Wesolowski, Kevin P. Delaney, Silvina Masciotra
Publikováno v:
Clinical Infectious Diseases. 64:53-59
Background Understanding the period of time between an exposure resulting in infection with human immunodeficiency virus (HIV) and when a test can reliably detect the presence of that infection, that is, the test window period, may benefit testing pr
Autor:
S. Michele Owen, William M. Switzer, Silvina Masciotra, Steven F. Ethridge, Rebecca Rossetti, Kevin P. Delaney, William Fowler, Pollyanna R Chavez, Tara Smith, Laura G. Wesolowski, Vickie Sullivan, Wei Luo, Emeka Oraka
Publikováno v:
Journal of Clinical Virology. 122:104214
Background Cepheid's Xpert HIV‐1 Viral Load (Xpert VL), a simplified, automated, single-use quantitative assay used with the GeneXpert System, is not FDA approved. Objectives Using stored plasma, we conducted a study to assess the ability of Xpert